TEL: (+62) 21 5890 1590
Venus Concept is a leader in the global medical and aesthetic device market, pairing best-in-class technology with the first and only true subscription model in the industry.
With the onset of selfie culture and the growing openness in discussions surrounding aesthetic treatments, it seems natural that we’re seeing a growing curiosity from prospective patients regarding medical aesthetic options at a younger age. But with Botox being recommended to patients are early as the time they hit their 20s and celebrities more openly admitting to their cosmetic procedures, including one 17-year-old who was credited with a 70% increase in inquiries regarding lip filler in the U.K. alone, it seems inquiries from younger patients may be expected. Of course, the ethics surrounding aesthetic treatments for teens is an area that remains a little murky. That’s why we’ve rounded up a list of the top guidelines when considering treatments for prospective patients under the age of 18.
Understanding regional regulations and establishing a guidebook for determining appropriate treatments for young patients (which may include defining what may be too young) are two necessary steps to ensure you and your staff are treating these patients in a responsible manner. Suggesting high-quality skin care or non-invasive treatment alternatives may be a more conservative way to deliver the results these patients want with little to no downtime and built-in safety features to ensure patient comfort. Further, a comprehensive long-term treatment plan may begin with preventative solutions and skin care essentials, working patients along to non-invasive and minimally invasive procedures once they mature. This is a safe and measured solution to ensure patient safety and optimal efficacy.
For versatility, consider Venus Versa™, a multi-treatment platform that offers some of the industry’s most in-demand aesthetic services—from acne reduction treatments to photorejuvenation, and IPL hair removal, among others—all in one easy-to-use workstation. Utilizing different applicators, physicians can customize a host of treatments to better serve a wider patient base. For those interested in learning more, contact an expert today using the contact button below.
For more information call: (+62 21) 5890 1590 // info.id@venusconcept.com // Ruko Business Park Kebon Jeruk Blok B11 Jl. Meruya Ilir Raya No. 88 Kel. Meruya Utara, Kec. Kembangan West Jakarta 11620
REGULATORY CLEARANCES [ More ]
All devices have received Indonesian Health Ministry Approval for sale and use in Indonesia. (Izin Edar Alat Kesehatan)
Venus Versa™ is cleared by the FDA, licensed by Health Canada, and has CE Mark as a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 applicators are cleared by the FDA, licensed by Health Canada, and have CE Mark for the treatment of benign pigmented epidermal and cutaneous lesions and treatment of benign cutaneous vascular lesions. The HR650/HR650XL and HR690/HR690XL applicators are cleared by the FDA, licensed by Health Canada, and have CE Mark for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for Fitzpatrick skin types I-IV. The AC Dual applicator is cleared by the FDA, licensed by Health Canada, and has CE Mark for the treatment of acne vulgaris. The DiamondPolar™ and OctiPolar™ applicators on the Venus Versa™ system are cleared by the FDA for non-invasive treatment of moderate to severe facial wrinkles and rhytides on females with Fitzpatrick skin types I-IV. The DiamondPolar™ applicator is licensed by Health Canada and has CE Mark for non-invasive treatment of moderate to severe facial wrinkles and rhytides on females with Fitzpatrick skin types I-IV. The OctiPolar™ applicator on the Venus Versa™ system is licensed by Health Canada and has CE Mark for temporary body contouring via skin tightening, circumferential reduction, and cellulite reduction. The NanoFractional RF™ (Viva) applicator is cleared by the FDA, licensed by Health Canada, and has CE Mark for dermatological procedures requiring ablation and resurfacing of the skin.
Venus Legacy™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in females with Fitzpatrick skin types I-IV with the OctiPolar™ and DiamondPolar™ applicators, and temporary reduction in the appearance of cellulite with the 4D Body (LB2) and 4D Face (LF2) applicators. It is licensed by Health Canada and has CE Mark for the temporary increase of skin tightening, temporary circumferential reduction, temporary cellulite reduction, and temporary wrinkle reduction.
Venus Viva™ is cleared by the FDA, licensed by Health Canada, and has CE Mark for dermatological procedures requiring ablation and resurfacing of the skin. The DiamondPolar™ applicator is licensed by Health Canada and has CE Mark for the treatment of moderate to severe wrinkles and rhytides in Fitzpatrick skin types I-IV.
Venus Freeze Plus™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in females with Fitzpatrick skin types I-IV. It is licensed by Health Canada for temporary skin tightening, and temporary reduction in the appearance of stretch marks at the abdomen and flanks, using the DiamondPolar™ and OctiPolar™ applicators. The DiamondPolar™ applicator on Venus Freeze Plus™ has CE Mark for the non-invasive treatment of moderate to severe facial wrinkles and rhytides, and the increase of skin tightening, temporary circumferential reduction, and cellulite reduction with the OctiPolar™ applicator.
Venus Glow™ is cleared by the FDA as a Class I motorized dermabrasion device. It provides a dermal rejuvenation treatment that works to open up and deep-clean pores. Venus Concept is the exclusive distributor for Venus Glow™.
Copyright © 2018 Venus Concept. All rights reserved.
You are entering our website. For other countries/regions and language options, please click the SELECT A DIFFERENT REGION button below.
SELECT A DIFFERENT REGIONAre you looking to get a treatment? Please visit our patient website to learn more.
Click Here